News & Analysis on Clinical Trial Services & Contract Research And Development
European regulators have been accused of making “no attempt” to counter misuse of prescription drugs in comparison with North American efforts to reformulate and restrict addictive drugs, according to a Canadian firm testing the abuse potential of medicines.
Novartis says it will continue to spend around $1m a week on clinical trials in the UK after its R&D site closes in June.
National prioritization, investments in healthcare infrastructure and building better epidemiological and cost databases could bring more innovative medicines to middle-income countries, according to an independent study conducted by Charles River...
BASF has hiked its prices for ethanolamines in Europe citing continuous demand increase.
Doctors, lawyers, State Department and World Bank spokesmen met on Wednesday to discuss the state of the Indian pharmaceutical world.
With a drive towards personalised medicine, Big Pharma is acting like mini-biotech firms in its approach to R&D, says Horizon Discovery who is launching a £25m ($42m) IPO.